High-concentration cannabis products are sending more young children to the hospital
A review found that pediatric cannabis hospitalizations are increasingly caused by high-concentration products like edibles and vaping fluid, causing sedation and respiratory depression in toddlers, while chronic use in adolescents leads to cognitive changes and hyperemesis.
Quick Facts
What This Study Found
Young children hospitalized for cannabis toxicity are increasingly exposed to high-concentration products (edibles, resins, vaping fluid) containing extremely high cannabinoid levels, leading to sedation, respiratory depression, and other adverse effects. Chronic adolescent use is associated with neurocognitive changes and cannabinoid hyperemesis syndrome.
Key Numbers
Products involved include edibles, resins, and vaping fluid with extremely high cannabinoid concentrations. Acute toxicity in young children: sedation, respiratory depression. Chronic adolescent toxicity: neurocognitive changes, cannabinoid hyperemesis.
How They Did This
Review of recent literature on THC pharmacokinetics, pharmacodynamics, developmental impacts, and presentations of acute and chronic cannabinoid toxicity in pediatric patients.
Why This Research Matters
Legalization has made high-potency cannabis products more accessible in households with children. The mismatch between these products (designed for adult tolerance) and pediatric vulnerability creates a growing emergency medicine challenge.
The Bigger Picture
The pediatric cannabis toxicity problem is a direct consequence of product design and packaging decisions in the legal cannabis market. Unlike with alcohol, many cannabis edibles resemble candy or food products attractive to children.
What This Study Doesn't Tell Us
Review-level evidence without pooled quantitative data. The specific incidence of pediatric exposures varies by state and over time. Not all product types are equally well-studied for pediatric effects.
Questions This Raises
- ?Are child-resistant packaging regulations sufficient?
- ?What are the long-term outcomes for toddlers with acute high-dose THC exposure?
- ?Should product design regulations specifically address appeal to children?
Trust & Context
- Key Stat:
- High-potency products = child risk
- Evidence Grade:
- Rated moderate because this is a clinical review synthesizing recent literature from a relevant pediatric perspective.
- Study Age:
- Published in 2019. Cannabis product diversity and potency have continued to increase since.
- Original Title:
- Cannabinoid toxicity in pediatrics.
- Published In:
- Current opinion in pediatrics, 31(2), 256-261 (2019)
- Authors:
- Blohm, Eike(2), Sell, Peter, Neavyn, Mark
- Database ID:
- RTHC-01950
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What happens when a young child eats cannabis edibles?
High-concentration cannabis products can cause sedation, respiratory depression, and other serious adverse effects in young children, who are much more sensitive than adults due to their smaller body size.
Are edibles the main concern?
Edibles, resins, and vaping fluids are the products most commonly involved in pediatric hospitalizations because they contain extremely high cannabinoid concentrations and may resemble regular food or candy.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBT-cannabis-recovery
- cannabis-relapse-cycle-pattern
- cold-turkey-vs-taper-quit-weed
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- how-to-quit-weed
- how-to-talk-to-teenager-about-weed
- journaling-weed-withdrawal
- kids-friends-smoke-weed-parent-guide
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- parent-smokes-weed-kids-hypocrite
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-parent
- quitting-weed-success-stories
- quitting-weed-teenager-young-adult
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- teenager-smoking-weed-parent-guide
- telling-friends-quitting-weed
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-01950APA
Blohm, Eike; Sell, Peter; Neavyn, Mark. (2019). Cannabinoid toxicity in pediatrics.. Current opinion in pediatrics, 31(2), 256-261. https://doi.org/10.1097/MOP.0000000000000739
MLA
Blohm, Eike, et al. "Cannabinoid toxicity in pediatrics.." Current opinion in pediatrics, 2019. https://doi.org/10.1097/MOP.0000000000000739
RethinkTHC
RethinkTHC Research Database. "Cannabinoid toxicity in pediatrics." RTHC-01950. Retrieved from https://rethinkthc.com/research/blohm-2019-cannabinoid-toxicity-in-pediatrics
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.